Should new oral anticoagulants replace low-molecular-weight heparin for thromboprophylaxis in orthopaedic surgery?

Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 133, 381S, 10.1378/chest.08-0656 Samama, 2006, Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines, Eur J Anaesthesiol, 23, 95, 10.1017/S0265021505002164 Eriksson, 2004, Significantly lower need for blood transfusions associated with postoperatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparin, Thromb Haemost, 92, 428, 10.1055/s-0037-1613733 Eriksson, 2006, A new oral anticoagulant, dabigatran etexilate, is effective and safe in preventing venous thromboembolism after total knee replacement surgery (the RE-MODEL trial), Blood, 573, 10.1182/blood.V108.11.573.573 Eriksson, 2007, Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial, Lancet, 370, 949, 10.1016/S0140-6736(07)61445-7 Ginsberg, 2009, Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery, J Arthroplasty, 24, 1, 10.1016/j.arth.2008.01.132 Caprini JA, Hwang SJ, Hantel S, et al. The oral direct thrombin inhibitor, dabigatran etexilate, is effective and safe for prevention of major venous thromboembolism following major orthopedic surgery. J Thromb Haemost 2007;5(Suppl. 2) [Abstr O-W-050]. Dahl O, Kurth AA, Rosencher N, et al. 150mg Dabigatran etexilate once daily has a good safety profile and comparable efficacy to enoxaparin for primary prevention of venous thromboembolism after total knee or hip replacement surgery in patients older than 75 years or with reduced renal function. Blood (ASH Annual Meeting Abstracts) 2008;112 [Abstract 437]. Eriksson, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty, N Engl J Med, 358, 2765, 10.1056/NEJMoa0800374 Kakkar, 2008, Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial, Lancet, 372, 31, 10.1016/S0140-6736(08)60880-6 Lassen, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty, N Engl J Med, 358, 2776, 10.1056/NEJMoa076016 Turpie AGG, Lassen MR, Kakkar AK, et al. A pooled analysis of four pivotal studies of rivaroxaban for the prevention of venous thromboembolism after orthopaedic surgery: effect on symptomatic venous thromboembolism, death, and bleeding. Blood (ASH Annual Meeting Abstracts) 2008;8:112 [Abstract 36].